Loading organizations...
§ Venture Capital · Singapore, Central Region, Singapore
Single-family office & venture capital firm for a Southeast Asian family, investing in healthcare, agriculture, 3D printing, food tech.
Key people at CrimsoNox Capital.
CrimsoNox Capital operates as a Singapore-based single-family office and venture capital firm. It strategically manages its founding family's assets, offering venture financing and capital support to startups. The firm’s investment approach emphasizes long-term value creation and sustainable growth across various sectors.
Established in 2015, CrimsoNox Capital represents Thailand's prominent Yoovidhya family. Their initial insight for founding the firm arose from their integral role in co-founding the globally recognized Red Bull brand. This substantial entrepreneurial background informs the firm’s discerning investment philosophy, guiding its selection of high-potential ventures.
The firm allocates capital and expertise to promising startups seeking growth funding and strategic guidance. CrimsoNox Capital aims to build a diversified portfolio that generates returns aligned with the family’s enduring legacy. Its vision is to foster future enterprises and ensure the sustained expansion of generational wealth.
Key people at CrimsoNox Capital.
CrimsoNox Capital has 2 tracked investments across 2 companies. The latest tracked deal is $80.0M Series D in Pear Therapeutics in December 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2020 | Pear Therapeutics | $80.0M Series D | Elena Viboch | F7 Ventures, General Catalyst, 5AM Ventures, Arboretum Ventures, EDBI, Forth Management, JAZZ Venture Partners, Novartis, Pilot House Ventures, Quad Investment Management, Sarissa Capital, Shanda Group, Temasek |
| Aug 5, 2019 | IVX Health | $22.5M Other Equity | Martin Felsenthal, Dave Schulte | Nueterra Capital |